stoxline Quote Chart Rank Option Currency Glossary
Kenvue Inc. (KVUE)
18.44  0.19 (1.04%)    07-17 16:00
Open: 18.27
High: 18.77
Volume: 16,890,162
Pre. Close: 18.25
Low: 18.27
Market Cap: 35,309(M)
Technical analysis
2024-07-17 5:28:34 PM
Short term     
Mid term     
Targets 6-month :  22.18 1-year :  25.9
Resists First :  18.98 Second :  22.18
Pivot price 18.21
Supports First :  18.17 Second :  17.67
MAs MA(5) :  18.21 MA(20) :  18.33
MA(100) :  19.37 MA(250) :  20.37
MACD MACD :  -0.2 Signal :  -0.3
%K %D K(14,3) :  50.6 D(3) :  43
RSI RSI(14): 50
52-week High :  25.22 Low :  17.67
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ KVUE ] has closed below upper band by 24.1%. Bollinger Bands are 52.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 18.79 - 18.86 18.86 - 18.92
Low: 18.08 - 18.17 18.17 - 18.24
Close: 18.31 - 18.44 18.44 - 18.55
Company Description

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Headline News

Wed, 17 Jul 2024
Kenvue Inc. (NYSE:KVUE) Shares Acquired by Russell Investments Group Ltd. - MarketBeat

Mon, 15 Jul 2024
Forsta AP Fonden Acquires 53,400 Shares of Kenvue Inc. (NYSE:KVUE) - Defense World

Mon, 15 Jul 2024
Kenvue Inc. (NYSE:KVUE) Stake Boosted by Empowered Funds LLC - Defense World

Sun, 14 Jul 2024
SG Americas Securities LLC Purchases 52,846 Shares of Kenvue Inc. (NYSE:KVUE) - Defense World

Sun, 14 Jul 2024
Kenvue Inc. (NYSE:KVUE) Short Interest Update - MarketBeat

Sat, 13 Jul 2024
Equity Investment Corp Acquires 328,934 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Consumer Defensive
Household & Personal Products
Shares Out 1,910 (M)
Shares Float 1,910 (M)
Held by Insiders 0 (%)
Held by Institutions 90.1 (%)
Shares Short 28,030 (K)
Shares Short P.Month 37,300 (K)
Stock Financials
EPS 0.77
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.55
Profit Margin 9.6 %
Operating Margin 17 %
Return on Assets (ttm) 5.9 %
Return on Equity (ttm) 9.6 %
Qtrly Rev. Growth 1.1 %
Gross Profit (p.s.) 0
Sales Per Share 8.1
EBITDA (p.s.) 1.88
Qtrly Earnings Growth -44.5 %
Operating Cash Flow 2,650 (M)
Levered Free Cash Flow 2,090 (M)
Stock Valuations
PE Ratio 23.64
PEG Ratio 11.9
Price to Book value 3.32
Price to Sales 2.27
Price to Cash Flow 13.29
Stock Dividends
Dividend 0.2
Forward Dividend 0
Dividend Yield 1%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android